Searched for
ORCHID PHARMA LENDERS
A 7,700% stock surge is about to face a reality check in IndiaOrchid is among a handful of Indian companies to post meteoric gains after exiting bankruptcy proceedings. Such rallies could pose consider...- Mandhana lenders move NCLT against buyout by US firmBankers say the US company failed to meet the terms of the pact as per agreed timeline.
- Stocks in the news: DHFL, IFCI, ICICI Lombard, SBI Life, NTPC and Bharti AirtelLarsen and Toubro (L&T) has increased its stake to 51% in IT services firm Mindtree.
- NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid PharmaA consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%.
- Accord wants Orchid to reconsider its bidTaking its chance, Accord, which had lost out to Dhanuka, filed a petition on June 14 asking for its bid to be considered.
- Dhanuka Laboratories leads race for Orchid PharmaBesides Dhanuka, two other companies - Accord Life Spec and Covalent Laboratories - had bid for Chennai-based Orchid Pharma in a second rou...
- Unable to pay up? Top bidder to face penalty under new rule of insolvency regulation“After the amendment, Section 74 of the insolvency code prescribes stringent punishment to resolution applicant if it fails to implement a ...
- Patanjali keen on buying Ruchi Soya as Adani Wilmar pulls out of dealRuchi Soya owes Rs 9,405 crore to lenders and Rs 1,248 crore to operational creditors.
- Ingen Capital sweetens Orchid Pharma offer, may acquire firmThe drug maker was among the 28 companies that the RBI mandated banks to refer to bankruptcy court by December 2017.
- Orchid Pharma faces liquidation as lenders reject resolution planOrchid Pharma was referred to the bankruptcy court by Lakshmi Vilas Bank after it failed to pay about Rs 3,500 crore to lenders.
- Stocks in focus on May 15, 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
- Orchid Pharma’s lenders reject Union Quimico’s bidThe resolution professional who is in charge of the management of the Chennai-based company has set April 25 as the fresh date for submitti...
- Banks gearing up to refer 24 of 28 large NPA accounts to NCLTIn August, the Reserve Bank had asked banks to either resolve the 28 more large stressed accounts or refer them to the NCLT by December 31.
- Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid PharmaOrchid was on the Reserve Bank of India's second list of 28 defaulters that had to be referred to the NCLT before December 31 if no resolut...
- Bankers look for speedy resolution of 28 accounts28 bad loan accounts need restructuring by December 13 or they’ll end up in NCLT, which will require banks to provide for losses of up to 5...
- Lenders of Orchid Pharma appoint Sripatham Ramkumar as resolution professionalLakshmi Vilas Bank has referred Orchid Pharma to National Company Law Tribunal and the court had admitted the company on August 17.
- PE funds, domestic pharma companies eye Orchid Pharma under IBCIn August, the NCLT Chennai had given the nod for insolvency proceedings against the company based on a plea filed by one of the lenders, L...
- ETMarkets After Hours: BoB bleeds on NSE exclusion; pharma in painHere's a look at the major movers and shakers of D-Street through the session.
- Orchid Chemicals surges 10% on approval of debt rejig planOrchid Chemicals surged nearly 10% on the back of reports that the CDR empowered group has approved the company's debt restructuring propos...
- Orchid may use warrants as defenceAs a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...
Load More
